Award of devices for patients on insulin therapy with infusion pumps and continuous glucose monitoring and related consumables

This tender involves the procurement of devices intended for patients undergoing insulin therapy, specifically those utilizing infusion pumps and continuous glucose monitoring systems, along with the necessary consumables. The contracting authority for this procurement is ASL LATINA. The tender is categorized under the CPV code for infusion devices and instruments, indicating a focus on medical supplies. The procurement process is classified as negotiated without prior publication of a call for tenders, which suggests a streamlined approach to awarding the contract. The location for the delivery of these devices is LATINA, Italy. The estimated value of the tender is EUR 586,619.88, reflecting the anticipated investment in these critical medical supplies. The contract has been awarded to ROCHE DIABETES CARE ITALY SPA, with the final award value set at EUR 584,856.56. This procurement aims to enhance the quality of care for patients requiring insulin therapy by providing advanced medical technology and support.

This is a supplies contract in the health and medical services sector, with a focus on Medical Equipment and Pharmaceuticals. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 584,857.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.